Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsStem CellsGraft vs Host DiseaseTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem CellsWhole-Body IrradiationBone and BonesTransplantation ConditioningStem Cell TransplantationAnemia, AplasticLeukemiaTransplantation ChimeraLiver TransplantationGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingCyclophosphamideHistocompatibilityCombined Modality TherapyHematopoiesisTransplantation, IsogeneicMice, Inbred C57BLCell DifferentiationBone Marrow DiseasesTreatment OutcomeKidney TransplantationTime FactorsRecurrenceRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteEmbryonic Stem CellsHematologic NeoplasmsRemission InductionBone Marrow ExaminationCell ProliferationSurvival AnalysisImmunosuppressive AgentsAdult Stem CellsAntineoplastic Combined Chemotherapy ProtocolsPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft RejectionHepatic Veno-Occlusive DiseaseRetrospective StudiesColony-Forming Units AssayBone RemodelingFlow CytometryBone Marrow NeoplasmsLeukemia, MyeloidTransplantation ImmunologyKidney NeoplasmsGraft vs Host ReactionLymphoma, Non-HodgkinImmunosuppressionCells, CulturedMesenchymal Stem Cell TransplantationLymphocyte DepletionSurvival RateCarcinoma, Renal CellChimeraAcute DiseaseLeukocyte TransfusionAntineoplastic AgentsT-LymphocytesFollow-Up StudiesHeart TransplantationDisease-Free SurvivalSevere Combined ImmunodeficiencyPrognosisBreast NeoplasmsMyelodysplastic SyndromesHLA AntigensMice, Inbred BALB CPluripotent Stem CellsNeoplasmsStem Cell NicheHematologic DiseasesCell LineageEtoposideMesenchymal Stromal CellsLung TransplantationActuarial AnalysisCell Line, TumorCyclosporineApoptosisLymphocyte TransfusionBone DensityAntigens, CD34Granulocyte Colony-Stimulating FactorCell DivisionCell SeparationCell SurvivalHematopoietic Stem Cell MobilizationCarmustine